Alan qualified in medicine at the University of Glasgow before training and practising as a family doctor in Scotland. His interest in diabetes led him to join Novo Nordisk, where he became UK Medical Director in 2001. He became a Member of the UK Faculty of Pharmaceutical Medicine in 2002 and a Fellow in 2013. After leaving Novo Nordisk and holding leadership roles at several companies, Alan joined Astellas as UK Medical Director in 2009, later moving into regional roles across APAC and Europe & Canada. He left Astellas in April 2025 and joined Mundipharma in November 2025 as Global Head of Medical Affairs.

Following Graduation in Medicine at the Free University Berlin, Michael pursued a career in General, Cardiovascular and Surgical Oncology in Germany and the UK, gaining an MD and an FRCS.  He joined pharmaceutical industry 25 years ago and has since been in clinical development, project leadership, and commercial and medical affairs roles at country, regional and global level. To date, Michael leads the Medical Affairs Team of Novartis Oncology, Region Europe.
Throughout his industry career, Michael mainly covered specialty care areas, e.g. Oncology and Immunology. He also qualified as a Pharmaceutical Physician and as an MBA. Research interests and publications are in Oncology and Immunology as well as in general aspects concerning Medical Affairs and Medicine Development in the Industry.

Daniél Vega Møller graduated in Medicine at the University of Copenhagen in 2000, where he also obtained his PhD within molecular cardio-genetics and heart failure. He has also been involved in the analysis of different biomarkers and their importance for prediction within the field of hypertension, CVD and obesity. After 10 years in the hospital setting in internal medicine, mainly cardiology, he moved to the pharma-industry and has been employed for more than 15 years focusing on drug development within the portfolio of insulin, obesity, liver health and metabolism, as well as Medial Affairs roles both at affiliate and regional level.

He is currently Vice President in the Strategic Operations of Novo Nordisk Health Care AG situated in the headquarter for international operations in Zürich, Switzerland. He is overall responsible for the Medical & Scientific Affairs activities focusing on cardiometabolic diseases like obesity, diabetes, cardio-vascular and chronic kidney diseases among others.

Olivia is an experienced leader working in the pharmaceutical industry for over 17 years, holding senior executive leadership positions throughout organizations of different sizes and in functions ranging from Patient Services, Medical Affairs, Marketing and Sales at local and international levels in Oncology, Rare Disease and Immunology.

She has managed products along the entire life-cycle with experience ranging from integrated evidence planning, Ph 3 go-to-market modeling through to management of loss of exclusivity .

She is a medical doctor with a Bachelor's Degree in Corporate Management and Entrepreneurship.

Also she holds a training in Healthcare System Transformation, experience as a DEI leader, and is a certified Coach.

Juan Vergez is VP, Head of Global Commercial Excellence at Mundipharma, where he leads global commercial capabilities, portfolio strategy and market access initiatives across the company's global portfolio. Previously, he served as General Manager for Spain and Portugal, leading commercial transformation and growth initiatives, including the successful launch of innovative therapies.

With more than 16 years of experience in biopharmaceuticals, specialty care, and rare diseases, Juan has held leadership roles spanning global strategy, marketing, communications, business operations, and general management across the US and international markets. He is passionate about building high-performing teams, accelerating commercial innovation, and helping healthcare organizations translate strategy into measurable impact for patients.

Natasha Hansjee, PhD, is a global principal scientific communication director at Roche. She is also  an executive coach and a storyteller. She has over 20 years of pharmaceutical marketing experience: sales, local & global strategic product management; global product commercial strategy training; scientific communications; mentoring, coaching and facilitating - and has worked across all stages of the life cycle (early launch, launch, LoE). 

Elizabeth Kupferer, PhD, WHNP-BC, is National Director of US Field Medical Affairs at Nestlé Health Science, where she leads field medical strategy for the gut microbiome portfolio, including a first-in-class oral live biotherapeutic for recurrent C. difficile infection. With extensive Medical Affairs leadership experience across the pharmaceutical, diagnostics, and device industries, and a track record of launching multiple first-in-class therapies at AbbVie, Novartis, Bausch Health, and Bayer, she brings deep expertise in building and leading high-performing MSL teams through complex scientific landscapes. A recognized thought leader in MSL professional development, Elizabeth is a member of the MSL Society Global Advisory Committee and a frequent speaker at Medical Affairs forums across the United States, Europe, and Asia. Her work centers on the evolving capabilities required of modern field medical professionals as they navigate precision medicine, emerging therapeutics, and an increasingly data-driven healthcare environment. Elizabeth holds a PhD from the University of Texas at Austin.

SSourav is currently the Head of Global Services, Medical and Scientific Affairs at Boehringer Ingelheim. He leads the Medical and Scientific Affairs Communication services hub in the Barcelona delivery unit, supporting our Medical Affairs teams in HQ and regions execute on their scientific communication priorities across Field and digital channels at scale. He has over 18 years of experience in the industry and has held medical engagement strategy and execution roles across Life Science companies driving capability building and change at scale in complex big pharma matrix environments.

Arnas is paediatrician with passion for vaccination and strong believe in prevention as a key intervention that can improve public health. 

He obtained his MD degree in Lithuania, Vilnius University, in 1996. Prior graduating, he also completed a clerkship in University of Wisconsin-Madison, USA. 

Dr Arnas Berzanskis has more than 27 years of experience in Pharmaceutical Industry. He has worked in multiple local, regional, global roles across a variety of business departments (medical, clinical, commercial) which allows him to have a strategic view of the industry. 

Arnas is currently supervising a team of talented scientists and entrepreneurs who are reshaping the medical landscape towards improved healthcare and prevention. 

His recent scientific publications in peer review journals focus on burden of RSV in adults. 

Ron Weathermon, PharmD, is a seasoned Medical Affairs leader with more than 25 years of experience spanning global, regional, and local roles in the pharmaceutical industry. As Head of Innovation and Scientific Excellence at Teva Global Medical Affairs, he drives the development of forward-looking medical strategies, fosters cross-functional collaboration, and champions scientific innovation and governance across the organization. Prior to joining Teva, Ron served as Global Head of Medical Affairs Governance at Novartis, where he led large-scale organizational transformations, established a global governance framework, and expanded medical field capabilities. Recognized for his ability to align scientific excellence with business strategy, he has built and developed high-performing teams, enhanced medical compliance systems, and integrated medical functions across diverse therapeutic areas—advancing both innovation and operational rigor.

Kaveri Sidhu, PhD, is Global Services Team Lead for Medical Writing at Boehringer Ingelheim, Spain. In her current role, she partners with global and local Medical Affairs teams to deliver scalable, technology-enabled scientific communications and evidence generation services across medical information, publications, medical communications, literature reviews, and HEOR/RWE. With over 12 years of experience spanning pharma, agency, and academia, Kaveri has held roles at Pfizer, Novartis, and Viatris, supporting the scientific communication and evidence needs of assets across the product lifecycle, from early pipeline and launch readiness to post-launch evidence generation and stakeholder engagement.

An expert in physician engagement. Maria partners with pharma to create meaningful connections with HCPs. She strives to inspire authentic dialogue, shape strategy, and deliver positive change in clinical practice.

Caroline Phillips is Vice President of Medical Affairs at Medscape, with over 25 years of experience in the pharmaceutical industry. Medscape Medical Affairs specialises in the translation of clinical science through effective medical communications to enhance patient care. With a background in pharma, medical publishing and CME, Caroline brings a broad perspective to conversations in medical affairs and a strong desire to optimise effectiveness in medical education, delivering programs that are guaranteed to engage the right HCP targets, with measurable impact. 

Chris Bassett is Sales Director for UK and Northern Europe at Springer Healthcare (part of the Springer Nature group).  Based in the UK, Chris started his Springer career as Commercial Partnership Manager, managing Springer’s relationships with key society and content stakeholders, such as ASCO and ASH.  In recent years, Chris has developed and now leads an expert team of educational content developers, delivering a wide range of solutions for healthcare professionals.   From in-person expert meetings and traditional print tools, through to interactive learning modules, live and on-demand webinars, and harnessing the power of digital opinion leaders.  Chris’s expertise lie in identifying the optimal content, delivered in the best format, to enact positive change for the healthcare industry.

Current role: AMICULUM head, AI and digital engagement

Steve has over 25 years’ experience in varied healthcare commercial roles spanning both client-side and agency businesses.

Over the last 14 years at AMICULUM, Steve has led the learning, events and specialist digital agency businesses, having overall responsibility for agency operations and programme delivery.

Steve has significant experience in designing and delivering high-quality internal training and capability programmes for commercial and medical teams and deploying digital engagement programmes to reach and inform external audiences.

Most recently Steve has taken on responsibility for the development and implementation of AMICULUM’s AI strategy, including the creation of new internal processes and service offerings.

Steve has expertise working in numerous therapy areas, including HIV, oncology, CV, vaccines and rare diseases.

Prior to joining AMICULUM Steve pioneered new forms of HCP digital engagement and educational approaches at Doctors.net (now M3) and gained significant client-side sales and marketing experience in his earlier career.

Steve holds a BSc in Management and Chemical Sciences from UMIST (Manchester University, UK).

Paulina Slaska works with some of the largest pharma companies to turn field and congress HCP interactions into a strategic engine for omnichannel engagement. With over eight years in the events industry, she brings a ground-level view of how live engagement data, captured right and routed into CRM, can power the entire commercial strategy.